Related Experiment Video
Updated: Aug 24, 2026

An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
Leishmania mexicana mexicana glucose-6-phosphate isomerase: crystallization, molecular-replacement solution and
Artur T Cordeiro1, Renaud Hardré, Paul A M Michels
1Laboratory of Protein Crystallography and Structural Biology, Physics Institute of São Carlos, University of São Paulo, USP, Av. Trabalhador Sãocarlense 400, PO Box 369, 13566-590 São Carlos-SP, Brazil.
Abstract:
Glucose-6-phosphate isomerase (PGI; EC 5.3.1.9; also often called by its old nomenclature phosphoglucose isomerase) is an intracellular enzyme that catalyses the reversible conversion of D-glucose 6-phosphate (G6P) to D-fructose 6-phosphate (F6P). The native Leishmania PGI is a homodimeric molecule of 60 kDa per monomer with 47% sequence identity to human PGI. It has been shown to be present in both the cytosol and the glycosome of Leishmania promastigotes and represents a potential target for rational drug design. The present work describes the crystallization of two bacterially expressed Leishmania PGI constructs, one corresponding to the natural protein and the other to an N-terminally deleted form. Crystals of both forms are identical and present a large c unit-cell parameter. A complete data set was collected from the N-terminally deleted PGI to a resolution of 3.3 A in space group P6(1), with unit-cell parameters a = b = 87.0, c = 354.7 A, alpha = beta = 90, gamma = 120 degrees. A preliminary study of the first inhibitors to be evaluated on the Leishmania enzyme is also reported.
More Related Videos
Related Concept Videos
Antiprotozoal Agents
Leishmaniasis

